Pathway Financial Advisers’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
22,492
+722
+3% +$102K 0.81% 49
2026
Q1
$2.85M Buy
21,770
+1,313
+6% +$189K 0.81% 46
2025
Q4
$2.72M Buy
20,457
+382
+2% +$50.7K 0.79% 44
2025
Q3
$2.63M Buy
20,075
+141
+0.7% +$19.2K 0.77% 44
2025
Q2
$2.66M Buy
19,934
+828
+4% +$95K 0.86% 39
2025
Q1
$2.09M Buy
19,106
+52
+0.3% +$6.27K 0.72% 47
2024
Q4
$2.36M Sell
19,054
-2,051,374
-99% -$249M 0.79% 41
2024
Q3
$18.9K Buy
2,070,428
+2,051,764
+10,993% +$221M 0.01% 255
2024
Q2
$2.05M Buy
18,664
+194
+1% +$21.5K 0.73% 44
2024
Q1
$2.09M Buy
18,470
+129
+0.7% +$13.3K 0.75% 44
2023
Q4
$1.79M Sell
18,341
-197
-1% -$18K 0.68% 52
2023
Q3
$1.79M Buy
+18,538
New +$1.77M 0.74% 47
2023
Q1
$1.65M Sell
18,970
-1,419
-7% -$124K 0.66% 55
2022
Q4
$1.96M Buy
+20,389
New +$1.83M 0.79% 43

Other funds holding EMR

Pathway Financial Advisers's EMR Position: Q2 2026 in Review

Pathway Financial Advisers increased its Emerson Electric (EMR) stake by 3.3% in Q2 2026, buying an estimated $102K and bringing the position to 22,492 shares worth $3.22M. The position accounts for 0.81% of the portfolio, ranked #49.

Pathway Financial Advisers first reported a position in EMR in Q4 2022 and has held it in 14 quarters since. 1,077 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • Pathway Financial Advisers held 22,492 shares of Emerson Electric worth $3.22M as of Q2 2026.
  • Pathway Financial Advisers bought 722 Emerson Electric shares in Q2 2026, an estimated $102K.
  • Emerson Electric made up 0.81% of Pathway Financial Advisers's portfolio in Q2 2026, its #49 holding.
  • Pathway Financial Advisers first reported a position in Emerson Electric in Q4 2022 and has held it in 14 quarters since.
  • 1,077 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.